H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) shares were down 0% on Monday . The stock traded as low as $22.00 and last traded at $22.00. Approximately 7,500 shares were traded during trading, an increase of 327% from the average daily volume of 1,758 shares. The stock had previously closed at $22.01.
H. Lundbeck A/S Stock Performance
The company has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32. The stock’s fifty day simple moving average is $22.00 and its 200-day simple moving average is $22.00.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Stories
- Five stocks we like better than H. Lundbeck A/S
- Best Stocks Under $5.00
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Roth IRA Calculator: Calculate Your Potential Returns
- Williams-Sonoma Stock: Buy It and Never Let It Go
- What Are Trending Stocks? Trending Stocks Explained
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
